ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis


We recently identified angiogenin (ANG) as a candidate susceptibility gene for amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder characterized by adult-onset loss of motor neurons. We now report the finding of seven missense mutations in 15 individuals, of whom four had familial ALS and 11 apparently 'sporadic' ALS. Our findings provide further evidence that variations in hypoxia-inducible genes have an important role in motor neuron degeneration.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: ANG mutations in ALS.


  1. 1

    Greenway, M.J. et al. Neurology 63, 1936–1938 (2004).

    CAS  Article  Google Scholar 

  2. 2

    Hayward, C. et al. Neurology 52, 1899–1901 (1999).

    CAS  Article  Google Scholar 

  3. 3

    Fett, J.W. et al. Biochemistry 24, 5480–5486 (1985).

    CAS  Article  Google Scholar 

  4. 4

    Shapiro, R., Fox, E.A. & Riordan, J.F. Biochemistry 28, 1726–1732 (1989).

    CAS  Article  Google Scholar 

  5. 5

    Shapiro, R. & Vallee, B.L. Biochemistry 28, 7401–7408 (1989).

    CAS  Article  Google Scholar 

  6. 6

    Moroianu, J. & Riordan, J.F. Proc. Natl. Acad. Sci. USA 91, 1667–1681 (1994).

    Article  Google Scholar 

  7. 7

    Kishimoto, K., Liu, S., Tsuji, T., Olson, K.A. & Hu, G.F. Oncogene 24, 445–456 (2005).

    CAS  Article  Google Scholar 

  8. 8

    Acharya, K.R., Shapiro, R., Allen, S.C., Riordan, J.F. & Vallee, B.L. Proc. Natl. Acad. Sci. USA 91, 2915–2919 (1994).

    CAS  Article  Google Scholar 

  9. 9

    Bond, M.D. & Vallee, B.L. Biochemistry 29, 3341–3349 (1990).

    CAS  Article  Google Scholar 

  10. 10

    Shapiro, R. & Vallee, B.L. Biochemistry 31, 12477–12485 (1992).

    CAS  Article  Google Scholar 

  11. 11

    Kieran, D.M. et al. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 6 (Suppl.), 42 (2005).

    Google Scholar 

  12. 12

    Oosthuyse, B. et al. Nat. Genet. 28, 131–138 (2001).

    CAS  Article  Google Scholar 

  13. 13

    Azzouz, M. et al. Nature 429, 413–417 (2004).

    CAS  Article  Google Scholar 

  14. 14

    Storkebaum, E. et al. Nat. Neurosci. 8, 85–92 (2005).

    CAS  Article  Google Scholar 

  15. 15

    Lambrechts, D. et al. Nat. Genet. 34, 383–394 (2003).

    CAS  Article  Google Scholar 

Download references


We are indebted to the patients, their families and referring neurologists for their participation in this project. We thank the following for their assistance with this study: M. Rogers, B. O'Hici, M. Russell, P. Connolly and D. Barton of the National Centre for Medical Genetics, Dublin, Ireland; E. Frost of the Irish Motor Neurone Disease Association; B. Corr, O. O'Toole, M. Alexander, B. Traynor and C. Lynch of Beaumont Hospital, Dublin, Ireland; D. McKenna-Yasek, W. Broom, S. Benn and P. Sapp of the Day Neuromuscular Research Laboratory, Boston; I. McLean of the University of Dundee; E. Goodall, H. Pall and K. Poulton of the University of Birmingham and S. Iyer of the University of Bath for the molecular modeling study on ANG mutants and Figure 1b. This work was supported in part by grants from the Health Research Board of Ireland (to M.G. and O.H.) and the Northern Ireland Research Office (V.P., C.D. and O.H.); by the Swedish Medical Society, the Björklund Foundation for ALS Research and the Hållstens Research Foundation (to P.A.); by the Wellcome Trust (UK) program grant 067288 (to K.R.A.); by the Scottish Motor Neurone Disease Association and the Scottish Home and Health Department (to R.S.); by the Motor Neurone Disease Association UK (to K.E.M.) and by the US National Institute of Neurological Disorders and Stroke, Project ALS, the ALS Association, the Al-Athel ALS Foundation and the Angel Fund (to R.H.B. and C.R.).

Author information



Corresponding authors

Correspondence to Matthew J Greenway or Orla Hardiman.

Ethics declarations

Competing interests

M.J.G. and O.H. are listed as inventors on a patent (UK patent number 0425625.1, 'Treatment of disease (use of angiogenin in neurodegenerative and axonal disease)') submitted to the UK Patent Office by the Royal College of Surgeons in Ireland.

Supplementary information

Supplementary Fig. 1

Angiogenin is expressed in mouse spinal cord motor neurons. (PDF 136 kb)

Supplementary Fig. 2

Expression of angiogenin in primary motoneuron cultures prepared from mouse. (PDF 3008 kb)

Supplementary Table 1

Clinical details of study populations. (PDF 24 kb)

Supplementary Table 2

Frequency of ANG rs11701 SNP genotypes. (PDF 34 kb)

Supplementary Table 3

Marker data for individuals with K17I and K40I mutations. (PDF 18 kb)

Supplementary Table 4

Amino acid residues involved in van der Waals contacts and hydrogen bonding interactions in the native crystal structure of ANG and mutated models. (PDF 16 kb)

Supplementary Methods (PDF 10 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Greenway, M., Andersen, P., Russ, C. et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 38, 411–413 (2006).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing